Abiogenesis Clinpharm Private Limited, a active private limited company, was established on 21 November 2014 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74930TG2014PTC096506. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹1.25 Cr.
It upholds a compliant status. Employing 28 professional, Its leadership includes Abraham Chikku Joseph (Director), Pawan Ishwarrao Bhusari (Director), Kalpesh Kumar Prabhudas Saglani (Additional Director). Past directors included Abraham Chikku Joseph, Snehal Bhusari. It holds ₹4.30 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 69, 8-2-248/1/7/69 Nagarjuna Hills, Punjagutta, Hyderabad, Telangana, 500082.
U74930TG2014PTC096506
096506
21 November 2014
₹1.25 Cr
₹1.25 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Abiogenesis Clinpharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abraham Chikku Joseph | Director | 26 Jul 2019 | Current |
| Pawan Ishwarrao Bhusari | Director | 21 Nov 2014 | Current |
| Kalpesh Kumar Prabhudas Saglani | Additional Director | 03 Nov 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 27 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abiogenesis Clinpharm Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 195.04% increase. The company also saw a substantial improvement in profitability, with a 319.64% increase in profit. The company's net worth Soared by an impressive increase of 162.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Abiogenesis Clinpharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹43,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2025 | Others | ₹3.00 Cr | Open |
| 01 Aug 2025 | Hdfc Bank Limited | ₹1.30 Cr | Open |
Explore comprehensive loan charge details -
Abiogenesis Clinpharm has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Abiogenesis Clinpharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abiogenesis Clinpharm's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kalpesh Kumar Prabhudas Saglani was appointed as a Additional Director was appointed as a Additional Director on 03 Nov 2025 & has been associated with this company since 1 month 27 days . was documented.
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101166448 was registered on 26 Sep 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.30 Cr with Charge ID 101139966 was registered on 01 Aug 2025. was completed.
Progress on Abiogenesis Clinpharm Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Abiogenesis Clinpharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Abraham Chikku Joseph was appointed as a Director was appointed as a Director on 26 Jul 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
The CIN of Abiogenesis Clinpharm Private Limited is U74930TG2014PTC096506.
Abiogenesis Clinpharm Private Limited is headquartered at Plot No 69, 8-2-248/1/7/69 Nagarjuna Hills, Punjagutta, Hyderabad, Telangana, 500082.
Abiogenesis Clinpharm Private Limited was incorporated on 21 November 2014.
The current directors of Abiogenesis Clinpharm Private Limited are
The primary industry of Abiogenesis Clinpharm Private Limited is Professional, Scientific And Technical.
Abiogenesis Clinpharm Private Limited is unlisted.
The authorized capital of Abiogenesis Clinpharm Private Limited is ₹1.25 Cr, and the paid-up capital is ₹1.25 Cr.
The compliance status of Abiogenesis Clinpharm Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX